Ayvens SA Completes First Phase of Share Buyback Program
News related to:Ayvens SA · 2 min read
Ayvens SA, a prominent company in its industry, announced the completion of the first phase of its share buyback program on 4 September 2026. The company began this initiative on 31 July 2026, as part of its strategy to enhance shareholder value and optimize capital structure. Ayvens SA has taken the necessary regulatory authorizations to carry out this ordinary share buyback program, which is aimed at repurchasing up to EUR 450 million worth of shares for cancellation.
As of 4 September 2026, Ayvens SA has executed transactions totaling 0.7% of its current share capital, corresponding to 14.0% of the overall buyback program. This activity was conducted on the regulated market of Euronext Paris and other trading platforms where the company's shares are listed. Notably, the liquidity contract Ayvens SA had with BNP Paribas Exane was suspended throughout the buyback period to ensure that the transactions were carried out in compliance with the relevant regulations.
The share buyback program is being managed in accordance with the provisions of the EU Regulation No. 596/2014 on Market Abuse, as modified, and its implementing provisions. The authorization for this program was granted by the combined General Shareholders' Meeting held on 13 May 2026, with specific resolutions 19 and 20.
Ayvens SA’s buyback program is part of its broader strategy to strengthen its financial position and provide greater value to shareholders. The company aims to use this program to reduce the number of outstanding shares, thereby increasing earnings per share and potentially boosting the share price. Ayvens SA continues to monitor market conditions and will adjust its buyback strategy as necessary to ensure that the program aligns with its overall financial goals.
The company’s commitment to shareholder value was reaffirmed through this buyback program. Ayvens SA’s management believes that such initiatives not only enhance the company’s financial health but also align with its long-term vision. The successful execution of the first phase of the share buyback program marks a significant step towards achieving these strategic objectives.